A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation

Diabetes Research and Clinical Practice

Volumn 89, Issue 3, 2010, Pages 231-238

  Karacay, Özlem ^a   Sepici Dincel, Aylin ^b   Karcaaltincaba, Deniz ^a   Sahin, Duygu ^b   Yalvaç, Serdar ^a   Akyol, Mesut ^c   Kandemir, Ömer ^a   Altan, Nilgün ^b  

^a Etlik Maternity and Women's Health Teaching Hospital   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Advanced oxidation protein product; Antioxidant status; Gestational diabetes mellitus; Lipid peroxidation products; Myeloperoxidase; Preeclampsia

Indexed keywords

INSULIN; LIPID HYDROPEROXIDE; MALONALDEHYDE; MYELOPEROXIDASE; OXYGEN RADICAL;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GESTATION PERIOD; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS;

EID: 77955424135     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.04.015     Document Type: Article

References (32)

1. Llesuy S., Evelson P., Campos A.M., Lissi E. Methodologies for evaluation of total antioxidant activities in complex mixtures. A critical review. Biol. Res. 2001, 34(2):51-73.
2. Serafini M., Del Rio D. Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?. Redox Rep. 2004, 9(3):145-152.
3. Summary and Recommendations of Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabtes 1991, 40(Suppl. 2):197-201.
4. Altan N., Sepici-Dincel A., Koca C. Diabetes mellitus and oxidative stress. Türk Biyokimya Dergisi [Turkish J. Biochem.] 2006, 31(2):1-56.
5. Harma M., Harma M., Erel O. Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur. J. Gynecol. Reprod. Biol. 2005, 118(1):47-51.
6. Llurba E., Gratacos E., Martin-Gallan P., Cabero L., Dominguez C. A comprehensive study of oxidative stres and antioxidant status in preeclampsia and normal pregnancy. Free Radic. Biol. Med. 2004, 37(4):557-570.
7. Roes E.M., Raijmakers M.T., Zusterzeel P.L., Knapen M.C., Peters W.H., Steegers E.A. Deficient detoxifying capacity in the pathophysiology of preeclampsia. Med. Hypotheses 2000, 55(5):415-418.
8. Brennan M.-L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., et al. Prognostic value of myeloperoxidase in patients with chest pain. New Engl. J. Med. 2003, 349:1595-1604.
9. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity, and its application to monitoring antioxidant status in premature neonates. Clin. Sci. 1993, 84:407-412.
10. Yoshioka T., Kawada K., Shimada T., Mori M. Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am. J. Obstet. Gynecol. 1979, 135:372-376.
11. Wolff S.P. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 1994, 233:182-189.
12. Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol. 1999, 300:58-62.
13. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., et al. Advanced oxidation protein products as a novel marker of oxidative strees in uremia. Kidney Int. 1996, 49:1304-1313.
14. Chen X., Scholl T.O. Oxidative stress: changes in pregnancy and gestational diabetes mellitus. Curr. Diab. Rep. 2005, 5:282-288.
15. Kharb S. Total free radical trapping antioxidant potential in preeclampsia. Int. J. Gynaecol. Obstet. 2000, 69(1):23-26.
16. Toescu V., Nuttall S.L., Martin U., Nightingale P., Kendall M.J., Brydon P., et al. Changes in plasma lipids and markers of oxidative stres in normal pregnancy and pregnancies complicated by diabetes. Clin. Sci. 2004, 106:93-98.
17. Kaur G., Mishra S., Sehgal A., Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol. Cell. Biochem. 2008, 313(1-2):37-44.
18. Peuchant E., Brun J.L., Rigalleau V., Dubourg L. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin. Biochem. 2004, 37(4):293-298.
19. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25(10):1862-1868.
20. ADA Position Statement: gestational diabetes mellitus. Diabetes Care 2004, 27(Suppl. 1):S88-S90.
21. Martín-Gallán P., Carrascosa A., Gussinyé M., Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic. Biol. Med. 2003, 34(12):1563-1574.
22. Santra D., Sawhney H., Aggarwal N., Majumdar S., Vasishta K. Lipid peroxidation and vitamin E status in gestational diabetes mellitus. J. Obstet. Gynaecol. Res. 2003, 29(5):3000-3004.
23. Chen X., Scholl T.O. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr. Diab. Rep. 2005, 5(4):282-288.
24. Anastasakis E., Papantoniou N., Daskalakis G., Mesogitis S., Antsaklis A. Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow. J. Obstet. Gynaecol. 2008, 28(3):285-289.
25. Diedrich F., Renner A., Rath W., Kuhn W., Wieland E. Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation. Am. J. Obstet. Gynecol. 2001, 185(1):166-172.
26. Regan C.L., Levine R.J., Baird D.D., Ewell M.G., Martz K.L., Sibai B.M., et al. No evidence for lipid peroxidation in severe preeclampsia. Am. J. Obstet. Gynecol. 2001, 185(3):572-578.
27. Casanueva E., Viteri F.E. Iron and oxidative stres in pregnancy. J. Nutr. 2003, 133:1700-1708.
28. Liu S.X., Hou F.F., Guo Z.J., Nagai R., Zhang W.R., Liu Z.Q., et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler. Thromb. Vasc. Biol. 2006, 26(5):1156-1162.
29. Mosaad A., Abou-Seif, Youssef A.-A. Evaluation of some biochemical changes in diabetic patients. Clin. Chim. Acta 2004, 346:161-170.
30. Fialova L., Kalousova M., Soukupova J., Malbohan I., Madar J., Frisova V., et al. Markers of inflammation in preeclampsia. Prague Med. Rep. 2004, 105(3):301-310.
31. Krzystek-Korpacka M., Salmonowicz B., Boehm D., Berdowska I., Zielinski B., Patryn E., et al. Diagnostic potential of oxidative stress markers in children and adolescents with type 1 diabetes. Clin. Biochem. 2008, 41(1-2):48-55.
32. Kharb S. Lipid peroksidation in pregnancy with preeclampsia and diabetes. Gynecol. Obstet. Invest. 2000, 50(2):113-116.